top of page


Gastrointestinal pathogen testing 

Acutis Reveal™ gastrointestinal infection test (GIT) offers a new definition of certainty:
it's an FDA-approved test that can detect up to 14 major gastrointestinal pathogens. 

This one-step, non-invasive stool test screens for infectious bacteria, viruses, and parasites in as few as 5 to 24 hours from the time the sample reaches our lab.

I would like to be contacted by an Acutis Expert 

Molecular detection of infectious diseases
eases and expedites the process



Additional confirmation requirements

Subtype detection of pathogens

Number of pathogens tested

Turnaround time

Acutis Reveal™ GIT

96% (92-100%)

98% (96-100%)




Within 24 hours of sample receipt

Stool Culture

Ova & Parasite

54% (48-60%)



Bacterial or viral only


2-3 days




Parasitic only


Up to 3 days

The FDA-approved test can detect
up to 14 major gastrointestinal pathogens

Reveal™ GIT viral targets

Reveal™ GIT bacterial targets

Reveal™ GIT parasitic targets

  • Adenovirus 40/41

  • Norovirus GI/GII

  • Rotavirus A

  • Campylobacter

  • Clostridium difficile toxins A & B

  • Enterotoxigenic E. coli (ETEC) LT/ST

  • Escherichia coli O157

  • Salmonella

  • Shiga-like Toxin producing E. coli (STEC) stx1/stx2

  • Shigella

  • Vibrio cholera

  • Cryptosporidium

  • Entamoebe histolytica

  • Giardia lamblia


Benefits of Acutis Reveal™ GIT at a glance

Simultaneous detection and identification of >90% of the bacteria, viral and parasitic pathogens responsible for infectious diarrhea

Breakthrough technology confirms a 99% Negative Predictive Value, encouraging best-practice treatment and patient care

Delivery of 95% of results the same day we receive the sample

Prevention of misdiagnoses and subsequent inappropriate use of antibiotics and other potentially costly actions

Minimal sample required for testing

Sans titre-2-1.jpg

Reveal™ GIT determines whether or not cases of diarrhea are infectious

Acutis Reveal™ gastrointestinal pathogen test can identify pathogens faster and with greater accuracy than any traditional methods or procedures. Highly accurate, the test detects and identifies >90% of infectious agents, providing the certainty clinicians require to provide the most efficient and efficacious patient care, in the shortest amount of time. 


Gastroenteritis is a growing problem. It too often frustrates the attending physician, always punishes the patient, and frequently puts others at risk.


Acutis Reveal™ offers a novel, proven, state-of-the-art technique that both diagnoses gastroenteritis while identifying specific viral, bacterial, or parasitic pathogens.

Reveal™ GIT determines the therapeutic course of action

The test quickly determines the specific bacteria, viral and parasitic pathogens causing the illness. With this knowledge, a medical provider can then take a more specific course of action. For example, if the bacterial toxin is identified as E. coli (STEC) or Shiga-like Toxin, the use of antibiotics may be appropriate. However, if it proves to be a case of Clostridium difficile toxins A and B, swift action may be called for due to its contagious nature.


For certain other patients, such as those with IBD, the ability to rule out infections is especially useful. In recent times, these particular pathogens have become notorious as they become better known to the general public.


Our test goes some way to ascertain a diagnosis, while calming the patients’ anxiety.


If you have any questions about the
Acutis Reveal™ gastrointestinal tests

Our molecular disease relations experts are available to speak with you to provide the information you need, to make individual test selections, based on your diagnoses and medical necessity.


acutis-website-source-main-REVEAL-4 copi

Discover all our Acutis Reveal™ tests for infectious disease 

bottom of page